Articles Tagged ‘Lung cancer’

Matthew Meyerson discusses TCGA lung squamous cell cancer study

Color head shot of Matthew Meyerson, TCGA investigator, wearing glasses.

Matthew Meyerson, M.D., Ph.D., a professor of pathology from the Harvard Medical School in Cambridge, Mass., and associate professor of pathology at the Dana-Farber Cancer Institute in Boston, led the writing committee for The Cancer Genome Atlas project on lung squamous cell cancer. He recently discussed his perspective on the findings.

Fagerstrom discusses landmark lung cancer screening trial

Richard Fagerstrom, Ph.D., an NCI mathematical statistician from the Division of Cancer Prevention, was the co-chief statistician for the National Lung Screening Trial, a nearly decade-long study that showed a 20 percent reduction in lung mortality among heavy smokers screening with low-dose CT, compared to those screened with X-ray. In this interview from June 2011, Fagerstrom discusses the trial, from concept design to primary results.

Overview of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

In 1993, the National Cancer Institute launched one of the largest cancer screening trials ever planned in the United States, in an effort to answer the question of screening efficacy in four cancers: prostate, lung, colorectal, and ovarian. Ten centers across the country ultimately accrued more than 150,000 men and women for this study. Nineteen years after it began, PLCO has now released the trial’s final major outcome finding, for colorectal cancer.